Algernon Health Inc.
AGNPF
$0.04
$0.0011.05%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 241.40K | 368.10K | 233.60K | 232.80K | 251.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 250.20K | 386.80K | 240.30K | 256.60K | 277.00K |
| Operating Income | -250.20K | -386.80K | -240.30K | -256.60K | -277.00K |
| Income Before Tax | -277.40K | -414.80K | -260.10K | -277.00K | -307.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -277.40K | -414.80K | -260.10K | -277.00K | -307.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -277.40K | -414.80K | -260.10K | -277.00K | -307.70K |
| EBIT | -250.20K | -386.80K | -240.30K | -256.60K | -277.00K |
| EBITDA | -225.10K | -380.60K | -236.10K | -252.60K | -273.10K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 34.29M | 29.04M | 27.30M | 27.30M | 23.39M |
| Average Diluted Shares Outstanding | 34.29M | 29.04M | 27.30M | 27.30M | 23.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |